Clinical trial
Erythrocyte-Mediated Drug Delivery for the Prevention of Restenosis After Coronary Artery Stent Implantation:TROY-Study
NCT00484965 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Erythrocyte-Mediated Drug Delivery for the Prevention of Restenosis After Coronary Artery Stent Implantation:TROY-Study
- Lead sponsor
- University of Rome Tor Vergata
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- July 31, 2007
- Completion date
- January 31, 2009
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.